Skip to content

Home
Stock Stories
US Equities
Ticker Update
Equity Analysis

Menu

Home
Stock Stories
US Equities
Ticker Update
Equity Analysis

SGMO

Tag
SGMO

Finance

Sangamo Therapeutics Inc. [SGMO] Revenue clocked in at $131.40 million, down -23.04% YTD: What’s Next?

Caleb Clifford July 2, 2021

Market

Wall Street Analyst Initiated Sangamo Therapeutics Inc. [SGMO]. What else is Wall St. saying

Annabelle Farmer July 1, 2021

Finance

Sangamo Therapeutics Inc. [SGMO] moved down -8.54: Why It’s Important

Annabelle Farmer May 6, 2021

Market

why Sangamo Therapeutics Inc. [SGMO] is a Good Choice for Investors After New Price Target of $19.80

Misty Lee March 22, 2021

Finance

Sangamo Therapeutics Inc. [SGMO] Revenue clocked in at $147.20 million, up 10.87% YTD: What’s Next?

Edison Baldwin December 8, 2020

Market

Sangamo Therapeutics Inc. [SGMO] stock Initiated by BofA Securities analyst, price target now $20

Brandon Evans November 5, 2020

Finance

Sangamo Therapeutics Inc. [SGMO] moved up 9.50: Why It’s Important

Brandon Evans October 12, 2020

Companies

Sangamo Therapeutics Inc. [SGMO] stock Initiated by BofA Securities analyst, price target now $20

Brandon Evans September 24, 2020

Finance

Sangamo Therapeutics Inc. [SGMO] gain 28.91% so far this year. What now?

Brandon Evans August 28, 2020

Companies

Sangamo Therapeutics Inc. [SGMO] moved down -0.87: Why It’s Important

Misty Lee August 5, 2020

« Previous Page1 Page2 Next »

Company

HomePage
About US
Our Team
Contact US
STOCK STORIES

Categories

Companies
Equity Analysis
Finance
Market
Stock Stories

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Email

© DBT NEWS. All rights reserved.

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

About Us
Contact Us
Homepage
Our Team
Thank You